Generex receives IND approval from FDA

Singapore, Dec. 14 -- Generex Biotechnology Corporation has announced that the FDA had reviewed the company's investigational new drug (IND) application and given notification that the study can proce... Read More

Lonza to establish new base in China using GE healthcare solution

Singapore, Dec. 13 -- Lonza has announced an agreement with GE Healthcare under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou, China. The new facility will give Lonza Pha... Read More

Merck collaborates to develop vaccines against dengue

Singapore, Dec. 13 -- Merck, known as MSD outside the United States and Canada, and Instituto Butantan, Sao Paulo, Brazil, a non-profit producer of immunobiologic products for Brazil have announced a ... Read More

Innovent declares positive result of IBI305, biosimilar to Avastin

Singapore, Dec. 13 -- Innovent Biologics, Inc. (Innovent), a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs, announced that IBI305, a recombinant... Read More

Cathay Biotech expands production capacity for new Bio-based materials

Singapore, Dec. 13 -- The government of the city of Wusu (Xinjiang, China) and Cathay Industrial Biotech Co., Ltd. ("Cathay") signed an agreement for the expansion of Cathay's production in Wusu. Cath... Read More

Researchers discover new compound to treat breast cancer

Singapore, Dec. 13 -- A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerability in laboratory tests when compared to similar agents, set... Read More

Luye Pharma submits its Parkinson's drug for clinical trial approval

Singapore, Dec. 13 -- Luye Pharma announced that its new investigational drug, Rotigotine Extended Release Microspheres for Injection (LY03003) for the treatment of Parkinson's disease has been submit... Read More

Novo Nordisk acquires platform for cell line development

Singapore, Dec. 13 -- Berkeley Lights, Inc. and Novo Nordisk have announced that Novo Nordisk has purchased the Beacon Optofluidic platform to accelerate workflows in cell line development and to use ... Read More

GHIT Fund to invest $4.6M for new projects on drug development

Singapore, Dec. 13 -- The Global Health Innovative Technology (GHIT) Fund has announced a total of 520 million yen ($4.6 million) to support four partnerships to develop new lifesaving drugs and vacci... Read More

Eisai, Takeda and GARDP sign pact to develop novel antibiotics

Singapore, Dec. 13 -- The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. and Takeda Pharmaceutical Company Limited have signed an agreement for GARDP to access and scr... Read More